A Phase 1b, Open-Label Study of DISC-3405 in Participants With Sickle Cell Disease (SCD)
A Phase 1b, Open-Label Study of DISC-3405 in Participants With Sickle Cell Disease (SCD)
Recruiting · NCT07187973 · Registry updated 2026-10-05Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase 1b, Open-Label Study of DISC-3405 in Participants With Sickle Cell Disease (SCD) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, anemia, familial hemolytic anemia, hematologic disorder, hemolytic anemia, hereditary disease, inherited hemoglobinopathy, sickle cell disease | Recruiting | Phase 1 | 2026-10-05 | NCT07187973 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Disc Medicine, Inc | 5 |
11 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Augusta University | Augusta | United States | 57 |
| Brody School of Medicine at East Carolina University | Greenville | United States | 7 |
| Cincinnati Children's Hospital Medical Center | Cincinnati | United States | 405 |
| Duke University Medical Center | Durham | United States | 7 |
| Emory University | Atlanta | United States | 262 |
| Innovative Hematology - Indiana Hemophilia & Thrombosis Center | Indianapolis | United States | 1 |
| Mount Sinai Hospital | New York | United States | 225 |
| University of Alabama at Birmingham | Birmingham | United States | 247 |
| University of California San Francisco (UCSF) Medical Center | San Francisco | United States | 1 |
| University of Illinois Hospital and Health Sciences System | Chicago | United States | 8 |
| University of Pittsburgh Medical Center (UPMC) | Pittsburgh | United States | 10 |